MENU
SLN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Silence Therapeutics (SLN) Earnings Date & Reports
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more
A.I. Advisor
published Earnings
SLN is expected to report earnings to rise 188.89% to -25 cents per share on November 05
Q3'26
Est.
$-0.26
Q2'26
Beat
by $0.05
Q1'26
Beat
by $0.03
Q4'25
Beat
by $0.11
Q3'25
Beat
by $0.04
The last earnings report on August 10 showed earnings per share of -9 cents, beating the estimate of -14 cents. With 1.30M shares outstanding, the current market capitalization sits at 1.22B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
12 Hammersmith Grove
Phone
+44 2034576900
Employees
88
Web
https://www.silence-therapeutics.com